NewGenIvf Group Ltd (NIVF) Stock Trading Recap
On Friday, NewGenIvf Group Ltd (NIVF) stock saw a decline, ending the day at $0.32 which represents a decrease of $-0.06 or -15.79% from the prior close of $0.38. The stock opened at $0.35 and touched a low of $0.31 during the day, reaching a high of $0.36. The volume of shares traded was 3.21 million falling short of the average volume of 6.02 million.
NIVF Stock Performance and Moving Averages
In recent trading, NewGenIvf Group Ltd (NIVF) stock price has shown some volatility, fluctuating -29.17% over the last five trades and -50.50% over the past 30 trades. This represents a notable shift from earlier in the year. Over the last six months, the stock has risen by -69.49%, and it has plunged by -54.50% in the previous three months. Currently, NIVF is trading at -27.47%, -54.37%, and -83.78% relative to its 20-Day, 50-Day, and 200-Day Simple Moving Averages, respectively.
Sponsored
As of the latest trading close, NIVF, a Health Information Services sector stock, is trading -98.16% below its 52-week high but remains 5.77% above its 52-week low. The Average True Range (ATR) (14 days) of 0.11 highlights the stock’s average volatility, providing insight into how much the price typically fluctuates. This measure is crucial for understanding potential price swings and assessing overall market risk.
NewGenIvf Group Ltd’s Profitability and Valuation Ratios
NewGenIvf Group Ltd’s profitability metrics reveal financial health. The company currently boasts a gross margin of -69.49%. The profit margin, also known as the revenue ratio or gross profit ratio, measures how efficiently a company converts sales into net income; higher margins indicate greater profitability.
In terms of valuation, NewGenIvf Group Ltd’s market capitalization stands at $3.22 million. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market value.
Understanding Insider Trading
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 70.81% of NewGenIvf Group Ltd (NIVF)’s shares, while financial institutions hold 1.36%.
